Malaysia
n researchers found that treatment with the anti-parasite drug ivermectin did not prevent patients with COVID-19 from becoming severely ill in a randomized clinical trial published in the JAMA Internal Medicine journal on Friday.The study enrolled 490 patients with mild to moderate illness at 20 hospitals and a COVID-19 quarantine center inSevere disease developed in 21.6% of the patients given ivermectin and in 17.3% of those who received only standard care, the researchers said.
There were no statistically significant differences between the groups in rates of ICU admission, need for mechanical ventilation, or death, according to the study. Doctors and patients all knew which group the patients had been assigned to, and this kind of"open-label" trial design could have introduced bias, potentially overestimating the effect of the drug, the researchers said.
The use of ivermectin to treat COVID-19 is currently being investigated in a UK trial run by the University of Oxford. The researchers have said they do not want to comment until they have results to report.- Reuters
Khairykj THINK DIFFERENT! What we need to do now is to develop an effective early preventive treatment protocol. Maybe IVM plus other medications. Vaccines are not a silver bullet. Not financially sustainable for the country and posed unknown long-term risks.
Khairykj
Mexico trial was 230,000. It was so successful they ended it early, recommended the use of Ivermectin and was the first country in the World to open up completely, now booming with tourists. Not that Ivermectin is relevant any more as Omicron is less severe than a bad cold.
I'm sure antivaxxers will disagree COVIDIOTS TrustNoOne
🥵